One of the special main characteristics of GermanOncology’s consulting services is its extremely high and broad oncological expertise: on the one hand, secured by the professional team of GermanOncology around Dr. Lipp, the centrally integrated experts, as well as the efficient organisation; and on the other hand, by the Germany-wide network of GermanOncology.
Practical consulting by experienced oncologists, expert development of individual solutions and strategic foresight are the three pillars on which GermanOncology’s consulting services are based.
Together with you, our customers from the healthcare sector, we develop future-oriented strategies and individual solutions, which we implement methodically, step by step.
You as our customer benefit from our comprehensive knowledge of the healthcare system and the short path to practical implementation – especially in the field of oncology. In this way, GermanOncology guarantees you a high degree of specialisation in your industry and the topic you are focusing on.
Get in touch with us to start the discussion. We look forward to hearing from you!
Rembursement- and revenue processes for oncological treatments
Cross-sectoral supply and collaboration models
Implementation of general conditions for specialists
Optimisation of the processes of new analysis methods
Support for market launches of new products and processes
Analyses of markets within Germany and other European countries
In addition to traditional support in the implementation of new oncological therapy options, our consulting services to pharmaceutical companies are primarily focused on novel approaches in the oncological market.
Early implementation of reimbursement- and revenue processes in marketing and sales strategies
Analysis and optimisation of process factors that can influence drug distribution and prescription, such as molecular genetic analysis
Written dossiers on the healthcare landscape or healthcare details in Germany, with reference to drugs or tumour diseases
Expansion of the market competence of pharmaceutical companies through a detailed understanding of supply structures
Implementation of directive requirements for specialist medical care, according to German Law e.g. § 116b SGB V
Establishment and restructuring of contract physicians' practices and structures including process analyses and optimisation, such as the development of IT tools for practise management, reimbursement processes, quality management and quality assurance
Preparation of business plans for supra-local structures and medical care centres through business and legal advice
Development of cross-sector or interdisciplinary supply structures, e.g. in the areas of collaboration, structures and networks
Establishment and operation of study centres
Using the reimbursement processes of various forms of oncological care
The solutions of GermanOncology are both complexly designed and modularly applicable. In this way, we can put them together according to your individual requirements. Exactly as you wish.c
We have developed the various solutions of GermanOncology in such a way that they dynamically adapt to your needs and internal requirements. Our individual team-formation for you is similar. For example, our own and external employees are not just anyone, but exclusively qualified specialists who we deploy in a targeted manner. We are efficient and innovative, at the same time. Innovative, because you can count on solutions for the future, from us. To this end, we invest in state-of-the-art technology, research and the consistent further development of our concepts. Efficient, because you can already use our future-oriented solutions today and will also benefit from them in the long term. Whether it concerns the deepening of the technical knowledge of your employees, analyses or the optimisation of processes: We support you to master your special challenges and to lead them to lasting success.
Ad-hoc analysis
Web-based revenue calculators
Development of selective contract concepts
Customized product developments
Training and workshops
Moderation and mediation
We – GermanOncology – offer current ad-hoc analyses of individual tumour diseases in Germany on the one hand in contractual medical care by physicians, and on the other hand, on therapy costs.
Chronic lymphatic leukaemia
Colorectal carcinomas
Breast cancers
Multiple myelomas
Myeloproliferative neoplasias
Non-small cell bronchial carcinoma
Renal cell carcinomas
Non-Hodgkin lymphomas
Pancreatic carcinomas
Urothelial carcinomas
Further tumour entities on request
Supportive therapy (e.g. antiemesis)
Colorectal carcinomas
Breast cancers
Non-small cell bronchial carcinoma
Non-Hodgkin lymphomas
Pancreatic carcinomas
Further tumour entities on request
In the future, selective contracts will be more closely integrated into medical care. Such selective contracts can cover complete areas of care, such as the treatment of prostate carcinoma, or even only important sub-areas such as molecular genetic analysis in non-small cell lung carcinoma. To develop such selective contract concepts in a meaningful way and also to be able to equip them with innovative remuneration systems on the basis of complex flat rates, among other things, an extensive collection and analysis of supply data are required. Thus, our concept developments are seamlessly integrated into the data collection via the Data4GO platform. The detailed cost analyses of medical services available in this way make it possible to develop economically interesting remuneration models for cost units as well.
For GermanOncology we train you and your employees in our solutions in detail so that you can subsequently work independently. Also, we offer training and workshops on the following topics:
Reimbursement processes in various forms of care
Impact and implementation of new legislation
Collaboration opportunities between clinics and practises
Teaching of oncological basics
Discussion with contract physicians on therapy behaviour in various - tumour diseases
In addition to the classic training courses and workshops, we offer you our expertise as moderators and mediators, for example on the following topics:
Establishment of cross-sector collaboration between clinics and practices
Optimisation of processes in practices and outpatient clinics
Formation of regional networks for medical care and studies